1. ‘A default mode of brain function’, Proceedings of the National Academy of Sciences, 98, pp. 676–82, doi: 10.1073/pnas.98.2.676.
2. ‘Wandering minds: the default network and stimulus-independent thought’, Science, 19 January 2007, vol. 315, no. 5810, pp. 393–5, doi: 10.1126/science.1131295.
3. ‘Intrinsic functional architecture in the anaesthetized monkey brain’, Nature, 3 May 2007, 447, pp. 83–6, doi: 10.1038/nature05758.
4. ‘Persistent default-mode network connectivity during light sedation’, Human Brain Mapping, July 2008, vol. 29, issue 7, pp. 839–47, doi: 10.1002/hbm.20537.
Horovitz, S., et al., ‘Low frequency BOLD fluctuations during resting wakefulness and light sleep: A simultaneous EEG-fMRI study’, Human Brain Mapping, 2008, 29, pp. 671–82, doi: 10.1002/hbm.20428.
5. Pagnoni, G., et al., ‘Thinking about not-thinking: neural correlates of conceptual processing during Zen meditation’. PLoS ONE, 2008, 3(9): e3083, doi: 10.1371/journal. pone.0003083.
1. Kaptchuk, Ted J., et al., ‘Placebos without deception: a randomized controlled trial in irritable bowel syndrome’, PLoS ONE, 2010, 5(12): e15591, doi: 10.1371/journal. pone.0015591.
2. Aspinwall, Lisa G., et al., ‘The value of positive psychology for health psychology: progress and pitfalls in examining the relation of positive phenomena to health’, Annals of Behavioral Medicine, February 2010, 39(1), pp. 4–15.
3. Chida, Y., and A. Steptoe, ‘Positive psychological well-being and mortality: a quantitative review of prospective observational studies’, Psychosomatic Medicine, September 2008, 70(7), pp. 741–56, doi: 10.1097.
4. Taylor, Shelley E., et al., ‘Are self-enhancing cognitions associated with healthy or unhealthy biological profiles?’, Journal of Personality and Social Psychology, October 2003, 85(4), pp. 605–15, doi: 10.1037/0022–3514.85.4.605.
5. Sherman, D. K., et al., ‘Psychological vulnerability and stress: the effects of self-affirmation on sympathetic nervous system responses to naturalistic stressors’, Health Psychology, September 2009, 28(5), pp. 554–62, doi: 10.1037/a0014663.
6. Hawkley, Louise C., ‘Loneliness matters: a theoretical and empirical review of consequences and mechanisms’, Annals of Behavioral Medicine, 2010, 40(2), pp. 218–27, doi: 10.1007/s12160–010–9210–8.
7. Jacobs, Tonya L., et al., ‘Intensive meditation training, immune cell telomerase activity, and psychological mediators’, Psychoneuroendocrinology, June 2011, 36(5), pp. 664–81.
8. Hölzel, Britta K., et al., ‘Stress reduction correlates with structural changes in the amygdala’, Social, Cognitive and Affective Neuroscience, 2010, 5(1), pp. 11–17, doi: 10.1093/scan/nsp034.
9. Whorwell, Peter J., ‘Hypnotherapy for irritable bowel syndrome: The response of colonic and noncolonic symptoms’, Journal of Psychosomatic Research, 2008, 64(6), pp. 621–3, doi: 10.1016/j.jpsychores.2008.02.022.
10. Mendoza, M. Elena, et al., ‘Efficacy of clinical hypnosis: A summary of its empirical evidence’, Papeles des Psicólogon, 2009, 30, p. 98.
11. Lissoni, P., et al., ‘A spiritual approach in the treatment of cancer: relation between faith score and response to chemotherapy in advanced non-small cell lung cancer patients, in vivo’, 2008, 22, pp. 577–82.
12. Chida, Y., et al., ‘Religiosity/spirituality and mortality, psychotherapy and psychosomatics’, 2009, 78, pp. 81–90, doi: 10.1159/000190791.
13. Kohls, Nikola, et al., ‘Spirituality: an overlooked predictor of placebo effects?’, Philosophical Transactions of The Royal Society B, 2011, 366(1572), pp. 1838–48.
1. Benedetti, F., et al., ‘Open versus hidden medical treatments: the patient’s knowledge about a therapy affects the therapy outcome’, Prevention & Treatment, 2003, 6, p. 1a, doi: 10.1037/1522–3736.6.1.61a.
2. Kaptchuk. Ted J., et al., ‘Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome’, BMJ, 2008, 336, pp. 999–1003, doi: 10.1136/bmj.39524.439618.25.
3. Colloca, Luana, et al., ‘Learning potentiates neurophysiological and behavioral placebo analgesic responses’, Pain, 2008, 139, pp. 306–14, doi: 10.1016/j. pain.2008.04.021.
4. Miller, Franklin G., and Ted J. Kaptchuk, ‘The power of context: reconceptualising the placebo effect’, Journal of the Royal Society of Medicine, 2008, 101, pp. 222–5, doi: 10.1258/jrsm.2008.070466.
5. Hróbjartsson, Asbjørn, and Peter C. Gøtzsche, ‘Placebo interventions for all clinical conditions’, The Cochrane Library, doi: 10.1002/14651858.CD003974.pub3.
1. Bollinger, R. Randal, et al., ‘Biofilms in the large bowel suggest an apparent function of the human vermiform appendix’, Journal of Theoretical Biology, 21 December 2007, 249(4), pp. 826–31, doi: 10.1016/j.jtbi.2007.08.032.
2. Nesse, Randolph M., and George C. Williams, ‘Evolution and the origins of disease’, Scientific American, November 1998, pp. 86–93.
3. Lucas, Peter W., ‘Facial dwarfing and dental crowding in relation to diet’, International Congress Series, June 2006, 1296, pp. 74–82, doi: 10.1016/j.ics.2006.03.041.
1. Baars, Bernard J., ‘In the theatre of consciousness: global workspace theory, a rigorous scientific theory of consciousness’, Journal of Consciousness Studies, 1997, 4(4), pp. 292–309.
2. Alkire, Michael T., et al., ‘Consciousness and anesthesia’, Science, 2008, 322(5903), pp. 876–80, doi: 10.1126/science.1149213.
3. Noirhomme, Quentin, et al., ‘Brain connectivity in pathological and pharmacological coma’, Frontiers in Systems Neuroscience, 20 December 2010, doi: 10.3389/fnsys.2010.00160.
4. Ku, Seung-Woo, et al., ‘Preferential inhibition of frontal-to-parietal feedback connectivity is a neurophysiologic correlate of general anesthesia in surgical patients’, PLoS One, doi: 10.1371/journal.pone.0025155.
5. Davis, Matthew H., et al., ‘Dissociating speech perception and comprehension at reduced levels of awareness’, Proceedings of the National Academy of Sciences, 104, pp. 16032–7, doi: 10.1073/pnas.0701309104.
1. http://www.aip.org/history/ohilist/4817.html
2. http://www.pbs.org/transistor/album1/shockley/
1. Meador, C. K., ‘Hex death: voodoo magic or persuasion?’, Southern Medical Journal, March 1992, 85(3), pp. 244–7.
2. Barsky, A. J., et al., ‘Nonspecific medication side effects and the nocebo phenomenon’, Journal of the American Medical Association, 6 February 2002, 287(5), pp. 622–7.
3. http://www.newscientist.com/article/dn16743.
4. Lorber, W., et al., ‘Illness by suggestion: expectancy, modeling, and gender in the production of psychosomatic symptoms’, Annals of Behavioral Medicine, February 2007, 331, pp. 112–16.
5. Scott, D. J., et al., ‘Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses’, Archives of General Psychiatry, February 2008, 65(2), pp. 220–31, doi: 10.1001/archgenpsychiatry.2007.34.
6. Eaker, E. D., et al., ‘Myocardial infarction and coronary death among women: psychosocial predictors from a 20-year follow-up of women in the Framingham Study’, American journal of epidemiology, 15 April 1992, 135(8), pp. 854–64.
7. Kharabsheh, Saad, et al., ‘Mass psychogenic illness following tetanusdiphtheria toxoid vaccination in Jordan’, Bulletin of the World Health Organization, 2001, 79, pp. 764–70, http://www.who.int/bulletin/archives/79(8)764.pdf.
1. Koon, Wang Sang, et al., ‘Constructing a low energy transfer between Jovian moons’, Contemporary Mathematics, 2002, 292, pp. 129–45.
2. Dellnitz, M., et al., ‘On target for Venus – set oriented computation of energy efficient low thrust trajectories’, Celestial Mechanics and Dynamical Astronomy, 2006, 95(1–4), pp. 357–70.
1. Wilson, C. M., et al., ‘Observation of the dynamical Casimir effect in a superconducting circuit’, Nature, 2011, 479, pp. 376–9, doi: 10.1038/nature10561.
2. Lamoreau, S. K., ‘Demonstration of the Casimir force in the 0.6 to 6 μm range’, Physical Review Letters, 1997, 78, pp. 5–8, doi: 10.1103/PhysRevLett.78.5.
3. Sushkov, A. O., et al., ‘Observation of the thermal Casimir force’, Nature Physics, 2011, 7, pp. 230–33, doi: 10.1038/nphys1909.
4. Maslovski, Stanislav I., and Mário G. Silveirinha, ‘Mimicking Boyer’s Casimir repulsion with a nanowire material’, Physical Review A, 2011, 83, p. 022508, doi: 10.1103/PhysRevA.83.022508.
5. Munday, J. N., et al., ‘Measured long-range repulsive Casimir–Lifshitz forces’, Nature, 2009, 457, pp. 170–73, doi: 10.1038/nature07610.
6. Rugh, Svend, and Henrik Zinkernagel, ‘The quantum vacuum and the cosmological constant problem’, arXiv:hep-th/0012253, http://philsci-archive.pitt.edu/id/eprint/398.
7. Moore, G. T., ‘Quantum theory of the electromagnetic field in a variable-length one-dimensional cavity’, Journal Mathematical Physics, 1970, 11, 2679, doi: 10.1063/1.1665432.
8. Wilson, op. cit.; see note 1.
1. Bean, W. B., ‘Nail growth: Thirty-five years of observation’, Archives of Internal Medicine, 1980, 140, pp. 73–6.
1. Khriachtchev, Leonid, et al., ‘A stable argon compound’, Nature, 2000, 406, pp. 874–6, doi: 10.1038/35022551.
2. Seidel, Stefan, and Konrad Seppelt, ‘Xenon as a complex ligand’, Science, 2000, 290, pp. 117–18, doi: 10.1126/science.290.5489.117.
1. Blair, S. N., ‘Physical inactivity: the biggest public health problem of the 21st century’, British Journal of Sports Medicine, 2009, 43, pp. 1–2.
2. Diabetes in the UK 2004, http://www.diabetes.org.uk/Professionals/Publications-reports-and-resources/Reports-statistics-and-case-studies/Reports/Diabetes_in_the_UK_2004/.
3. Flegal, K. M., et al., ‘Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999– 2010’, The Journal of the American Medical Association, 2012, 307(5), pp. 491–7, doi: 10.1001/jama.2012.39.
4. Al-Shayji, I. A. R., et al., ‘Effects of moderate exercise on VLDL1 and Intralipid kinetics in overweight/obese middle-aged men’, American Journal of Physiology and Metabolism, 2012, 302(3), pp. E349–55, doi: 10. 1152/ajpendo. 00498. 2011.
5. Diabetes Prevention Program Research Group, ‘Reduction in the incidence of type 2 diabetes with lifestyle intervention or Metformin’, New England Journal of Medicine, 2002, 346, pp. 393–403, doi: 10.1056/NEJMoa012512.
6. Richter, E. A., et al., ‘Muscle glucose metabolism following exercise in the rat: increased sensitivity to insulin’, The Journal of Clinical Investigation, 1982, 69(4), pp. 785–93, doi: 10.1172/JCI110517.
7. Wojtaszewski, J. F., et al., ‘Insulin signaling and insulin sensitivity after exercise in human skeletal muscle’, Diabetes, 2000, 49(3), pp. 325–31, doi: 10.2337/diabetes.49.3.325.
8. Funai, K., et al., ‘Increased AS160 phosphorylation, but not TBC1D1 phosphorylation, with increased postexercise insulin sensitivity in rat skeletal muscle’, American Journal of Physiology, Endocrinology and Metabolism, 2009, 297(1), pp. E242–51, doi: 10.1152/ajpend0.00194.2009.
9. Holmes, M. D., ‘Physical activity and survival after breast cancer diagnosis’, The Journal of the American Medical Association, 2005, 293(20), pp. 2479–86, doi: 10.1001/jama.293.20.2479.
10. Slattery, M. L., and J. D. Potter, ‘Physical activity and colon cancer: confounding or interaction?’, Medicine and Science of Sports Exercise, 2002, 34(6), pp. 913–19.
11. McTiernan, A., et al., ‘Effect of a 12-month exercise intervention on patterns of cellular proliferation in colonic crypts: a randomized controlled trial’, Cancer Epidemiology, Biomarkers & Prevention, 2006, 15, p. 1588, doi: 10.1158/1055–9965.EPI-06–0223.
12. He, C., et al., ‘Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis’, Nature, 2012, 481, pp. 511–15, doi: 10.1038/nature10758.
13. van Praag, H., et al., ‘Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus’, Nature Neuroscience, 1999, 2, pp. 266–70, doi: 10.1038/6368.
14. Erickson, K. I., et al., ‘Exercise training increases size of hippocampus and improves memory’, Proceedings of the National Academy of Sciences, 2011, 108(7), pp. 3017–22, doi: 10.1073/pnas.1015950108.
15. Chaddock, L., et al., ‘A neuroimaging investigation of the association between aerobic fitness, hippocampal volume, and memory performance in preadolescent children’, Brain Research, 2010, 1358, pp. 172–83.
16. Steeves, J. A., ‘Energy cost of stepping in place while watching television commercials’, Medicine & Science in Sports & Exercise, 2012, 44, pp. 330–35, doi: 10.1249/MSS.0b013e31822d797e.
17. Sui, X., et al., ‘Cardiorespiratory fitness and adiposity as mortality predictors in older adults’, The Journal of the American Medical Association, 2007, 298(21), pp. 2507–16, doi: 10.1001/jama.298.21.2507.
18. Wen, C. P., and Xifeng Wu, ‘Stressing harms of physical inactivity to promote exercise’, The Lancet, 2012, 380(9838), pp. 192–3, doi: org/10.1016/S0140–6736(12)60954–4.